Taseko Mines
TGB · TORONTO
About TGB
- Employees
- 703
- Headquarters
- Vancouver, British Columbia
- Listed
- May 22, 1981
- Sector
- Materials
- Industry
- Metals & Mining
- Website
- tasekomines.com
TGB key statistics
- Market cap
- 3.75B
- Price-earnings ratio
- 260.71
- Dividend yield
- —
- Average volume
- 4.17M
- Volume
- 5.38M
- Open price
- $7.28
- High today
- $7.58
- Low today
- $7.26
- 52 Week high
- $9.82
- 52 Week low
- $3.93
Taseko Mines (TGB) at a glance
Taseko Mines (TGB) last traded at $7.46, with a market cap of 3.75B and a price-to-earnings ratio of 260.71.
Today the stock has traded between $7.26 and $7.58. The current price is 2.8% above the day's low and 1.5% below its high.
Volume so far is 5.38M shares, above the average of 4.17M shares a day.
Over the past year Taseko Mines has ranged from $3.93 to $9.82, and now sits 60% of the way up that range.
Taseko Mines met or beat analyst EPS estimates in 1 of the last 8 quarters. In Q2 FY26 it reported $0.11 per share against an estimate of $0.096.
The average analyst price target is $10.59, 42.0% above the current price, from 1 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy100.0%
- Hold0.0%
- Sell0.0%
- Low
- $9.72
- Now
- $7.46
- High
- $11.97
TGB earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 1 of the last 8 quarters, by 14.6% on average.
- Q3 FY24: reported $0.03 per share against an estimate of $0.0364
- Q4 FY24: reported $0.03 per share against an estimate of $0.0303
- Q1 FY25: reported -$0.02 per share against an estimate of $0.00
- Q2 FY25: reported -$0.04 per share against an estimate of -$0.0364
- Q3 FY25: reported $0.02 per share against an estimate of $0.0404
- Q4 FY25: reported $0.11 per share against an estimate of $0.1246
- Q1 FY26: reported $0.08 per share against an estimate of $0.1212
- Q2 FY26: reported $0.11 per share against an estimate of $0.096
TGB news
- Press releaseGlobe Newswire
- Press releaseGlobe Newswire
Trekor Announces 41 Million Pounds of Copper Production from Gibraltar and Florence Copper in the Third Quarter
'Antofagasta Copper Miners to Strike as High Prices Fan Tensions' - Bloomberg
- Press releasePRNewswire
Tungsten Has Tripled in 2026 as U.S. Explorers Race to Drill
- Press releaseGlobe Newswire
Trekor Updates Status of Aley Niobium and Strengthens Project Team
- Press releaseGlobe Newswire
Trekor Announces $125 Million of Adjusted EBITDA in Second Quarter
- Press releaseGlobe Newswire
Trekor to Release Second Quarter 2026 Results
- Press releaseGlobe Newswire
Trekor Announces 36 Million Pounds of Copper Production from Gibraltar and Florence Copper in the Second Quarter
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.